Your browser doesn't support javascript.
Respiratory viruses: New frontiers-a Keystone Symposia report.
Cable, Jennifer; Sun, Jie; Cheon, In Su; Vaughan, Andrew E; Castro, Italo A; Stein, Sydney R; López, Carolina B; Gostic, Katelyn M; Openshaw, Peter J M; Ellebedy, Ali H; Wack, Andreas; Hutchinson, Edward; Thomas, Mallory M; Langlois, Ryan A; Lingwood, Daniel; Baker, Steven F; Folkins, Melanie; Foxman, Ellen F; Ward, Andrew B; Schwemmle, Martin; Russell, Alistair B; Chiu, Christopher; Ganti, Ketaki; Subbarao, Kanta; Sheahan, Timothy P; Penaloza-MacMaster, Pablo; Eddens, Taylor.
  • Cable J; PhD Science Writer, New York, New York, USA.
  • Sun J; Division of Pulmonary and Critical Medicine, Department of Medicine; Department of Immunology; and Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA.
  • Cheon IS; Carter Immunology Center and Division of Infectious Disease and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Vaughan AE; Division of Pulmonary and Critical Medicine, Department of Medicine; Department of Immunology; and Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA.
  • Castro IA; Carter Immunology Center and Division of Infectious Disease and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Stein SR; University of Pennsylvania School of Veterinary Medicine, Biomedical Sciences, Philadelphia, Pennsylvania, USA.
  • López CB; Virology Research Center, Ribeirao Preto Medical School, University of São Paulo - USP, São Paulo, Brazil.
  • Gostic KM; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Openshaw PJM; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Ellebedy AH; Department of Molecular Microbiology and Center for Women Infectious Disease Research, Washington University School of Medicine, St Louis, Missouri, USA.
  • Wack A; Department of Ecology and Evolution, University of Chicago, Chicago, Illinois, USA.
  • Hutchinson E; Department of Respiratory Medicine, Imperial College London, London, UK.
  • Thomas MM; Department of Pathology and Immunology; The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs; and Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St Louis, Missouri, USA.
  • Langlois RA; Immunoregulation Laboratory, The Francis Crick Institute, London, UK.
  • Lingwood D; MRC - University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Baker SF; Montana State University, Bozeman, Montana, USA.
  • Folkins M; Center for Immunology and Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Foxman EF; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Ward AB; Lovelace Biomedical Research Institute, Albuquerque, New Mexico, USA.
  • Schwemmle M; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Russell AB; Department of Laboratory Medicine and Department of Immunology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Chiu C; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
  • Ganti K; Institute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Subbarao K; Division of Biological Sciences, University of California, San Diego, La Jolla, California, USA.
  • Sheahan TP; Department of Infectious Disease, Imperial College London, London, UK.
  • Penaloza-MacMaster P; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Eddens T; Department of Microbiology and Immunology, WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute for Infection and Immunity, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Ann N Y Acad Sci ; 1522(1): 60-73, 2023 04.
Article in English | MEDLINE | ID: covidwho-2313313
ABSTRACT
Respiratory viruses are a common cause of morbidity and mortality around the world. Viruses like influenza, RSV, and most recently SARS-CoV-2 can rapidly spread through a population, causing acute infection and, in vulnerable populations, severe or chronic disease. Developing effective treatment and prevention strategies often becomes a race against ever-evolving viruses that develop resistance, leaving therapy efficacy either short-lived or relevant for specific viral strains. On June 29 to July 2, 2022, researchers met for the Keystone symposium "Respiratory Viruses New Frontiers." Researchers presented new insights into viral biology and virus-host interactions to understand the mechanisms of disease and identify novel treatment and prevention approaches that are effective, durable, and broad.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Syncytial Virus Infections / Influenza, Human / COVID-19 Limits: Humans Language: English Journal: Ann N Y Acad Sci Year: 2023 Document Type: Article Affiliation country: Nyas.14958

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Syncytial Virus Infections / Influenza, Human / COVID-19 Limits: Humans Language: English Journal: Ann N Y Acad Sci Year: 2023 Document Type: Article Affiliation country: Nyas.14958